Department of Internal Medicine, University of Iowa, Iowa City, IA 52242, USA.
J Exp Med. 2010 Jul 5;207(7):1359-67. doi: 10.1084/jem.20100147. Epub 2010 Jun 7.
A recessive mutation named Justy was found that abolishes B lymphopoiesis but does not impair other major aspects of hematopoiesis. Transplantation experiments showed that homozygosity for Justy prevented hematopoietic progenitors from generating B cells but did not affect the ability of bone marrow stroma to support B lymphopoiesis. In bone marrow from mutant mice, common lymphoid progenitors and pre-pro-B cells appeared normal, but cells at subsequent stages of B lymphopoiesis were dramatically reduced in number. Under culture conditions that promoted B lymphopoiesis, mutant pre-pro-B cells remained alive and began expressing the B cell marker CD19 but failed to proliferate. In contrast, these cells were able to generate myeloid or T/NK precursors. Genetic and molecular analysis demonstrated that Justy is a point mutation within the Gon4-like (Gon4l) gene, which encodes a protein with homology to transcriptional regulators. This mutation was found to disrupt Gon4l pre-mRNA splicing and dramatically reduce expression of wild-type Gon4l RNA and protein. Consistent with a role for Gon4l in transcriptional regulation, the levels of RNA encoding C/EBPalpha and PU.1 were abnormally high in mutant B cell progenitors. Our findings indicate that the Gon4l protein is required for B lymphopoiesis and may function to regulate gene expression during this process.
发现一种名为 Justy 的隐性突变,它能消除 B 淋巴样细胞生成,但不损害造血的其他主要方面。移植实验表明,Justy 纯合子阻止造血祖细胞生成 B 细胞,但不影响骨髓基质支持 B 淋巴样细胞生成的能力。在突变小鼠的骨髓中,普通淋巴样祖细胞和前 B 细胞似乎正常,但 B 淋巴样细胞生成的后续阶段的细胞数量明显减少。在促进 B 淋巴样细胞生成的培养条件下,突变的前 B 细胞仍然存活,并开始表达 B 细胞标记物 CD19,但不能增殖。相比之下,这些细胞能够生成髓样或 T/NK 前体。遗传和分子分析表明,Justy 是 Gon4 样(Gon4l)基因内的点突变,该基因编码与转录调节剂同源的蛋白质。该突变被发现破坏 Gon4l 前体 mRNA 的剪接,并显著降低野生型 Gon4l RNA 和蛋白质的表达。与 Gon4l 在转录调节中的作用一致,突变体 B 细胞祖细胞中编码 C/EBPalpha 和 PU.1 的 RNA 水平异常升高。我们的研究结果表明,Gon4l 蛋白是 B 淋巴样细胞生成所必需的,可能在该过程中调节基因表达。